Akoustis & Cornell v. Qorvo: GaN Epitaxial Process Patent Dismissed With Prejudice
Akoustis Technologies, Akoustis Inc., Cornell University, and Cornell Research Foundation jointly sued Qorvo over US7250360B2 — a Cornell-originated patent covering epitaxial AlN, AlGaN, and GaN semiconductor growth processes — targeting Qorvo’s QPD1000 device. The case ended after 600 days via joint stipulation of dismissal with prejudice, with each party bearing its own costs.
Cornell GaN Process Patent Triggers E.D. Texas Dispute With Qorvo
Filed on 20 April 2023 in the Eastern District of Texas, this infringement action was brought by Akoustis Technologies, Inc., Akoustis, Inc., Cornell University, and Cornell Research Foundation, Inc. against Qorvo, Inc. The central patent-in-suit, US7250360B2, covers a process for growing epitaxial layers of AlN, AlGaN, or GaN on lattice-mismatched substrates — a foundational technique for wide-bandgap semiconductor fabrication. Plaintiffs alleged that Qorvo’s QPD1000 device practiced this patented process.
The case closed on 10 December 2024 via a joint stipulation of dismissal with prejudice — meaning all claims, counterclaims, and affirmative defenses asserted by all parties are permanently extinguished. The Court accepted and acknowledged the stipulation, denying all pending relief as moot. Crucially, neither side was awarded costs, expenses, or attorneys’ fees, a neutral cost allocation that typically accompanies a negotiated resolution rather than a unilateral capitulation.
At 600 days, the case ran a full pre-trial cycle before resolving — suggesting the parties likely engaged in substantial claim construction and discovery before reaching terms. The public record does not disclose any licensing agreement, financial consideration, or technical concession underlying the stipulation. The ‘with prejudice’ designation bars any re-filing of these specific claims, providing Qorvo with finality on the asserted patent while leaving the broader GaN epitaxial IP landscape — including other Akoustis and Cornell-held patents — unresolved.
Filing to Dismissed with Prejudice in 600 days
600 days from filing to dismissal — roughly 20 months, typical for E.D. Texas patent cases settling before trial
Dismissed with prejudice: what the joint stipulation means for both parties
Dismissal with prejudice bars re-filing on these claims
A dismissal with prejudice under Fed. R. Civ. P. 41 is a final adjudication on the merits for res judicata purposes. The specific claims asserted in this case — infringement of US7250360B2 by the QPD1000 and the related process — cannot be re-litigated between these parties. The joint nature of the stipulation signals a negotiated endpoint rather than a unilateral withdrawal, though the precise terms remain confidential.
Permanent bar on re-filingAkoustis and Cornell lose litigation leverage on this patent
With prejudice dismissal means Akoustis Technologies, Akoustis Inc., Cornell University, and Cornell Research Foundation cannot assert US7250360B2 against Qorvo on the QPD1000 again. The patent itself remains in force and may still be asserted against other defendants, but the dismissal removes it as an enforcement tool specifically against Qorvo for the conduct at issue. No cost award suggests the outcome was commercially negotiated.
Patent survives; Qorvo-specific barQorvo secures permanent resolution of this infringement action
Qorvo obtains a with-prejudice dismissal covering all claims and its own counterclaims and affirmative defenses — providing clean finality. The mutual dismissal of counterclaims suggests Qorvo may have had invalidity or non-infringement defenses in play. Each side bearing its own costs is consistent with a settlement structure in which neither party conceded liability. Qorvo’s QPD1000 product is no longer subject to this specific litigation threat.
Full finality; no liability findingGaN epitaxial process IP remains a live risk for the sector
US7250360B2 covers a pre-treatment process step critical to GaN-on-silicon and GaN-on-SiC device fabrication — a method broadly relevant to RF power amplifiers, 5G front-end modules, and defence electronics. The with-prejudice dismissal resolves the Qorvo dispute but does not invalidate the patent. Other GaN device manufacturers operating similar epitaxial growth processes should assess their exposure to this Cornell-originated IP and related portfolio continuations.
Broader GaN sector risk persistsFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Akoustis Technologies, Inc. | Company | Semiconductor IP commercialisation and university technology transfer — holder of US7250360B2Search in Eureka ↗ |
| Co-Plaintiff | Cornell University | Individual | Search in Eureka ↗ |
| Co-Plaintiff | Cornell Research Foundation, Inc. | Company | Search in Eureka ↗ |
| Co-Plaintiff | Akoustis, Inc. | Company | Search in Eureka ↗ |
| Defendant | Qorvo, Inc. | Company | Qorvo, Inc. — global RF semiconductor manufacturer, maker of the accused QPD1000 deviceSearch in Eureka ↗ |
| Plaintiff counsel | Caroline Elyse Burks | Attorney | Counsel for Akoustis Technologies, Inc.Search in Eureka ↗ |
| Plaintiff counsel | George Theodore Fishback , Jr. | Attorney | Counsel for Akoustis Technologies, Inc.Search in Eureka ↗ |
| Plaintiff counsel | James E Quigley | Attorney | Counsel for Akoustis Technologies, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Jennifer Leigh Truelove | Attorney | Counsel for Akoustis Technologies, Inc.Search in Eureka ↗ |
| Plaintiff counsel | John Bruce Campbell , Jr. | Attorney | Counsel for Akoustis Technologies, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Kyle N. Ryman | Attorney | Counsel for Akoustis Technologies, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Samuel Franklin Baxter | Attorney | Counsel for Akoustis Technologies, Inc.Search in Eureka ↗ |
| Plaintiff law firm | McKool Smith PC | Law Firm | Representing Akoustis Technologies, Inc.Search in Eureka ↗ |
| Plaintiff law firm | McKool Smith PC (Marshall) | Law Firm | Representing Akoustis Technologies, Inc.Search in Eureka ↗ |
| Plaintiff law firm | McKool Smith PC (Austin) | Law Firm | Representing Akoustis Technologies, Inc.Search in Eureka ↗ |
| Defendant counsel | Darren Matthew Franklin | Attorney | Counsel for Qorvo, Inc.Search in Eureka ↗ |
| Defendant counsel | Jennifer Klein Ayers | Attorney | Counsel for Qorvo, Inc.Search in Eureka ↗ |
| Defendant counsel | Jonathan R DeFosse | Attorney | Counsel for Qorvo, Inc.Search in Eureka ↗ |
| Defendant counsel | Kazim Naqvi | Attorney | Counsel for Qorvo, Inc.Search in Eureka ↗ |
| Defendant counsel | Mark Thomas Ratway | Attorney | Counsel for Qorvo, Inc.Search in Eureka ↗ |
| Defendant counsel | Robert M. Masters | Attorney | Counsel for Qorvo, Inc.Search in Eureka ↗ |
| Defendant counsel | Roy Jung | Attorney | Counsel for Qorvo, Inc.Search in Eureka ↗ |
| Defendant counsel | Timothy P Cremen | Attorney | Counsel for Qorvo, Inc.Search in Eureka ↗ |
| Defendant counsel | Zachary Alper | Attorney | Counsel for Qorvo, Inc.Search in Eureka ↗ |
| Defendant law firm | Sheppard Mullin Richter & Hampton LLP – DC | Law Firm | Representing Qorvo, Inc.Search in Eureka ↗ |
| Defendant law firm | Sheppard Mullin Richter & Hampton LLP (Dallas) | Law Firm | Representing Qorvo, Inc.Search in Eureka ↗ |
| Defendant law firm | Sheppard Mullin Richter & Hampton, LLP | Law Firm | Representing Qorvo, Inc.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The Court’s order closely tracks the joint stipulation language, accepting and acknowledging — rather than independently adjudicating — the dismissal. This phrasing confirms the outcome is entirely consent-driven: the Court made no finding on infringement, validity, or damages. The mutual dismissal of counterclaims and affirmative defenses, combined with the symmetric cost allocation, is consistent with a confidential settlement in which neither party made a public concession. US7250360B2 emerges from this litigation with its validity untested and enforceable against third parties.
US7250360B2 — Epitaxial GaN/AlN/AlGaN growth process on mismatched substrates
US7250360B2, originating from Cornell University (application number US11/069040), protects a semiconductor fabrication process in which epitaxial layers of aluminium nitride (AlN), aluminium gallium nitride (AlGaN), or gallium nitride (GaN) are grown on lattice-mismatched substrates. The distinguishing claim element is a pre-treatment step: the substrate surface is exposed to at least one Group III reactant — or Group II reactant — at an elevated growth temperature before any Group V or Group VI reactant is introduced. This nucleation approach is designed to improve crystal quality and reduce defect density in wide-bandgap semiconductor devices.
GaN-on-SiC and GaN-on-Si processes governed by this type of nucleation sequence are foundational to modern RF power amplifiers, 5G base-station front-end modules, and high-electron-mobility transistors (HEMTs). Cornell’s patent, commercialised through Akoustis, represents a strategic upstream IP position: any manufacturer using MOCVD or similar techniques with a Group III pre-treatment step on a mismatched substrate could fall within the claim scope. The patent’s enforceability against Qorvo was never tested on the merits, leaving its commercial threat to the broader RF semiconductor ecosystem intact.
Should you run an FTO against US7250360B2 for your GaN epitaxial process?
Any R&D team or product group developing GaN-on-SiC, GaN-on-Si, or AlGaN/GaN HEMT devices using MOCVD or HVPE growth should assess their fabrication process against US7250360B2. The critical claim question is whether your epitaxial growth sequence involves pre-treating the substrate with a Group III species — such as trimethylgallium or trimethylaluminium — at elevated temperature before introducing nitrogen or another Group V precursor. This sequence is common in commercial MOCVD nucleation layers and may map onto the patent’s independent claims.
PatSnap Eureka’s FTO Search Agent can map your specific process parameters against the claim language of US7250360B2 and surface related Cornell and Akoustis continuation patents that may carry forward similar claim scope. Eureka’s semantic claim analysis identifies process step overlaps that keyword searches miss, and its portfolio monitoring alerts you to new prosecution activity from Cornell Research Foundation — giving your legal and engineering teams the lead time to design around or challenge claims before litigation risk materialises.
Run a freedom-to-operate analysis on US7250360B2 to assess your product’s exposure
Run FTO in Eureka →Similar GaN semiconductor process patent cases in E.D. Texas
Cases involving GaN epitaxial process patents and wide-bandgap semiconductor infringement disputes filed in the Eastern District of Texas, including RF device and HEMT-related actions.
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable Qorvo’s QPD1000-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedAkoustis Technologies, Inc.’s broader IP enforcement history
Akoustis Technologies, Inc.’s full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this case signals for the GaN semiconductor IP landscape
The Akoustis-Cornell v. Qorvo dismissal highlights how university-commercialised process patents remain potent enforcement tools in the RF semiconductor space.
University-originated process patents are increasingly monetised via litigation
Cornell Research Foundation’s co-plaintiff role demonstrates the growing trend of research universities actively enforcing foundational semiconductor process patents through commercial partners. Companies operating GaN epitaxial growth lines should audit their fabrication processes against Cornell’s patent portfolio, particularly pre-treatment steps involving Group III reactants at elevated temperatures.
E.D. Texas remains a preferred venue for semiconductor process patent disputes
Plaintiffs chose the Eastern District of Texas — a historically plaintiff-friendly venue with efficient scheduling. For defendants like Qorvo, this creates early pressure to engage. The 600-day duration to a with-prejudice dismissal suggests the parties used the full pre-trial window, including likely Markman proceedings, before reaching commercial terms. Monitor this court for related Akoustis or Cornell filings.
Qorvo’s counterclaim dismissal may signal invalidity arguments that never reached verdict
The mutual dismissal of counterclaims — including Qorvo’s affirmative defenses — means potential invalidity arguments against US7250360B2 were never adjudicated. This leaves the patent’s validity untested in court, potentially strengthening its use against future defendants who cannot benefit from any Qorvo-developed prior art record.
QPD1000 architecture signals which product families remain at risk
Qorvo’s QPD1000 is a GaN-on-SiC RF power transistor. The process patent claim — specifically pre-treating substrates with Group III reactants before Group V introduction — maps broadly to standard MOCVD nucleation sequences. Competitors using similar GaN-on-SiC or GaN-on-Si MOCVD processes for RF and power devices should treat this case as a proxy for their own exposure to US7250360B2 and related continuations.
Akoustis v Qorvo — key questions answered
The case was dismissed with prejudice via joint stipulation on 10 December 2024, after 600 days of litigation. All claims, counterclaims, and affirmative defenses between all parties were dismissed. Each party was ordered to bear its own costs, expenses, and attorneys’ fees. No finding on infringement or validity was made.
US7250360B2 is a Cornell University patent covering a process for growing epitaxial GaN, AlN, or AlGaN layers on lattice-mismatched substrates, distinguishing itself by pre-treating the substrate with a Group III or Group II reactant at elevated temperature before introducing Group V or VI reactants. Plaintiffs alleged Qorvo’s QPD1000 GaN-on-SiC RF transistor was manufactured using a process that infringed this method.
No. A dismissal with prejudice by joint stipulation is a consent-based procedural termination, not a merits ruling. The Court made no finding on the validity or invalidity of US7250360B2. The patent remains in force and can be asserted against other parties. Qorvo’s potential invalidity arguments, which were included as counterclaims, were also dismissed without being adjudicated.
The QPD1000 is a GaN-on-SiC RF power transistor manufactured by Qorvo, used in high-frequency power amplification applications. Plaintiffs identified it as an accused product because its fabrication allegedly involves an epitaxial growth process using a Group III pre-treatment step on a lattice-mismatched substrate — the specific process element protected by US7250360B2.
Courts order each party to bear its own costs when a case resolves by mutual agreement without a prevailing party determination. The symmetric cost allocation in this case is consistent with a negotiated commercial resolution — potentially a licensing arrangement or covenant not to sue — rather than either side conceding defeat. The specific financial or licensing terms, if any, are not part of the public record.
Monitor GaN semiconductor process patent risk with PatSnap Eureka
US7250360B2 emerged from this case with its validity untested and its claims intact. Run an FTO on your GaN epitaxial fabrication process and track Cornell and Akoustis continuation filings before the next enforcement action is filed.
PatSnap Eureka searches patents and litigation data to answer instantly.